St. Jude Medical resolves FDA warning letter for Sylmar facility St. Jude Medical announced that it has been notified by the U.S. Food and Drug Administration that issues cited in the Sylmar, California facility’s warning letter have been addressed. The company said, “We take our responsibility as a medical device manufacturer very seriously. We are encouraged by the resolution of the FDA’s warning letter and will continue to work to ensure the highest standards are met across our manufacturing facilities. St. Jude Medical is committed to providing our patients, customers and regulators with products and services that meet or exceed their expectations of safety, high-quality performance, reliability and service.”
News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.